PIDD1
Basic information
Region (hg38): 11:799179-809753
Previous symbols: [ "LRDD", "PIDD" ]
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder (Strong), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
- Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly (2 variants)
- not provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PIDD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | |||||
missense | 125 | 11 | 138 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 7 | |||||
Total | 3 | 4 | 127 | 20 | 7 |
Highest pathogenic variant AF is 0.0000197
Variants in PIDD1
This is a list of pathogenic ClinVar variants found in the PIDD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-799313-C-G | Inborn genetic diseases | Uncertain significance (Jul 30, 2024) | ||
11-799318-C-T | Inborn genetic diseases | Uncertain significance (May 26, 2022) | ||
11-799340-C-T | PIDD1-related disorder | Likely benign (Feb 28, 2019) | ||
11-799356-G-C | Inborn genetic diseases | Uncertain significance (Jun 29, 2023) | ||
11-799358-G-C | Benign (Dec 14, 2017) | |||
11-799383-C-T | Inborn genetic diseases | Uncertain significance (Jul 30, 2024) | ||
11-799386-C-T | Inborn genetic diseases | Likely benign (Aug 08, 2023) | ||
11-799403-C-G | Inborn genetic diseases | Uncertain significance (Jan 03, 2025) | ||
11-799404-T-C | Uncertain significance (Feb 21, 2024) | |||
11-799410-C-T | Inborn genetic diseases | Uncertain significance (Sep 08, 2024) | ||
11-799411-G-A | Inborn genetic diseases | Likely benign (Oct 17, 2024) | ||
11-799414-C-T | Uncertain significance (Apr 22, 2022) | |||
11-799431-C-T | Inborn genetic diseases | Uncertain significance (Aug 08, 2024) | ||
11-799432-G-A | Inborn genetic diseases | Uncertain significance (Aug 03, 2022) | ||
11-799435-C-A | Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly | Uncertain significance (Sep 08, 2024) | ||
11-799453-G-A | Intellectual disability • Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly | Pathogenic (Apr 20, 2022) | ||
11-799456-G-A | Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly | Pathogenic (Nov 16, 2023) | ||
11-799516-G-A | Inborn genetic diseases | Uncertain significance (Sep 26, 2024) | ||
11-799536-A-G | Inborn genetic diseases | Uncertain significance (Jan 23, 2025) | ||
11-799575-G-A | PIDD1-related disorder | Likely benign (Nov 06, 2019) | ||
11-799584-C-T | not specified | Likely benign (Aug 11, 2023) | ||
11-799797-G-C | not specified | Likely benign (Aug 11, 2023) | ||
11-799816-G-A | Inborn genetic diseases | Uncertain significance (Nov 07, 2022) | ||
11-799822-C-T | Inborn genetic diseases | Uncertain significance (Mar 06, 2023) | ||
11-799828-G-A | Inborn genetic diseases | Uncertain significance (Mar 31, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PIDD1 | protein_coding | protein_coding | ENST00000347755 | 15 | 10575 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.44e-17 | 0.0986 | 125445 | 0 | 108 | 125553 | 0.000430 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.838 | 634 | 577 | 1.10 | 0.0000396 | 5617 |
Missense in Polyphen | 223 | 210.35 | 1.0601 | 2282 | ||
Synonymous | -1.74 | 287 | 252 | 1.14 | 0.0000158 | 2098 |
Loss of Function | 1.07 | 29 | 35.9 | 0.807 | 0.00000190 | 362 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000956 | 0.000862 |
Ashkenazi Jewish | 0.00172 | 0.00169 |
East Asian | 0.000771 | 0.000762 |
Finnish | 0.000250 | 0.000231 |
European (Non-Finnish) | 0.000355 | 0.000335 |
Middle Eastern | 0.000771 | 0.000762 |
South Asian | 0.000629 | 0.000588 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Promotes apoptosis downstream of the tumor suppressor as component of the DNA damage/stress response pathway that connects p53/TP53 to apoptosis. Associates with NEMO/IKBKG and RIP1 and enhances sumoylation and ubiquitination of NEMO/IKBKG which is important for activation of the transcription factor NF-kappa-B. Associates with CASP2/caspase-2 and CRADD/RAIDD, and induces activation of CASP2 which an important regulator in apoptotic pathways. {ECO:0000269|PubMed:10973264, ECO:0000269|PubMed:15073321, ECO:0000269|PubMed:16360037}.;
- Pathway
- p53 signaling pathway - Homo sapiens (human);Apoptosis - Homo sapiens (human);NF-kappa B signaling pathway - Homo sapiens (human);miRNA Regulation of DNA Damage Response;Apoptosis Modulation and Signaling;ATM Signaling Pathway;TP53 Regulates Transcription of Cell Death Genes;DNA Damage Response;Gene expression (Transcription);Generic Transcription Pathway;TP53 Regulates Transcription of Cell Death Genes;RNA Polymerase II Transcription;TP53 Regulates Transcription of Caspase Activators and Caspases;Transcriptional Regulation by TP53;Direct p53 effectors;Caspase Cascade in Apoptosis
(Consensus)
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- rvis_EVS
- -1.38
- rvis_percentile_EVS
- 4.36
Haploinsufficiency Scores
- pHI
- 0.121
- hipred
- N
- hipred_score
- 0.454
- ghis
- 0.578
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Pidd1
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- apoptotic process;activation of cysteine-type endopeptidase activity involved in apoptotic process;cellular response to DNA damage stimulus;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;signal transduction;inorganic anion transport;protein autoprocessing;regulation of apoptotic process;positive regulation of apoptotic process;negative regulation of apoptotic process;regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of NF-kappaB transcription factor activity;anion transmembrane transport;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
- Cellular component
- nucleus;nucleoplasm;cytoplasm;Golgi apparatus;cytosol;ion channel complex
- Molecular function
- endopeptidase activity;death receptor binding;volume-sensitive anion channel activity;protein binding